MUCINOUS ADENOCARCINOMA OVARY: DIAGNOSTIC DILEMMA AND THE USEFULNESS OF COLONOSCOPY
AbstractBackground: Ovarian carcinoma is the fourth most common malignant disease of women. Types of ovarian carcinoma, including serous, mucinous, endometrioid, and transitional carcinoma, differ from each other with respect to morphology, genetic alterations and in their clinical course.Ovary is a common site for tumour metastases with 5–30% of ovarian cancers metastatic in nature. Differentiating primary from metastatic mucinous ovarian adenocarcinoma is often challenging. We assessed the usefulness of colonoscopy to sort out this dilemma. Methods: In this case-series with retrospective data collection at a tertiary care hospital in Pakistan, demographics, indication for referral, tumour size, laterality, and the immuno-histochemical stains were recorded. Results: A total of 17 patients were referred to gastroenterology department between March 2009 and March 2012. Mean age of the patients was 36.7 years (range, 16-58 years) and the indication for referral was mucinous pathology. All of these patients had surgery outside hospital; histopathology was submitted at our pathology laboratory for review. Out of 17 patients, 16 had progressive abdominal distension as the primary symptom whereas one patient had a history of bleeding per rectum; 67% (12/17) of the tumours were more than 10cm and 94% (16/ 17) were unilateral. We were able to find the colorectal primary in 17.4% (3/17) of the patients, whereas upper GI endoscopies were unrevealing all patients. CK-7 was positive in two of three and CK-20 was positive in all the three patients with colorectal primary. Conclusion: We were able to identify gastrointestinal primary in significant number of patients without gastrointestinal symptoms that showed immuno-histochemical stain pattern of primary mucinous adenocarcinoma and had a tumour size of greater than 10cm and were unilateral.Keywords: Mucinous adenocarcinoma of the ovary, Colonoscopy, Algorithm
Ferly J, Shin HR, Bray F, Forman D, Mather’s C, Parkin DM. Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008. Int J Cancer 2010;127(12):2893–917.
Kelemen LE, Kobel M. Mucinous carcinomas of the ovary and colorectum: different organs, same dilemma. Lancet Oncol 2011;12(11):1071–80.
Lee SJ, Bae JH, Lee AW, Tong SY, Park YG, Park JS. Clinical characteristics of metastatic tumours to the ovaries. J Korean Med Sci 2009;24(1):114–9.
Harrison ML, Jameson C, Gore ME. Mucinous ovarian cancer. Int J Gynecol Cancer 2008;18(2):209–14.McCluggage WG. Immunohistochemistry in the distinction between primary and metastatic ovarian mucinous neoplasms. J Clan Pathol 2012;65(7):596–600.
Lash RH, Hart WR. Intestinal adenocarcinomas metastatic to the ovaries. A clinic pathologic evaluation of 22 cases. Am J Surg Pathol 1987;11(2):114–21.
Moertel CG. Chemotherapy for colorectal cancer. N Engl J Med 1994;330(16):1136–42.
Qazi F, McGuire WP. The treatment of epithelial ovarian cancer. Cancer J Clin 1995;45(2):88–101.
Seidman JD, Kurman RJ, Ronnett BM. Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol 2003;27(7):985–93.
Yemelyanova AV, Vang R, Judson K, Wu LS, Ronnett BM. Distinction of primary and metastatic mucinous tumours involving the ovary: analysis of size and laterality data by. Primary site with reevaluation of an algorithm for tumour classification. Am J Surg Pathol 2008;32(1):128–38.
Shin HJ, Bae JH, Lee A, Jung CK, Yim HW, Park JS, et al. CK7, CK20, CDX2 and MUC2 immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma. Jpn J Clin Oncol 2010:40;208–213.
NCCN clinical practice guidelines in oncology. Ovarian cancer including fallopian tube cancers and primary peritoneal cancers Version3..2012.
Lee SJ, Bae JH, Lee AW, Tong SY, Park YG, Park JS. Namkoong SE, Park JS. Clinical characteristics of metastatic tumours to the ovaries. J Korean Med Sci 2009;24(1):114–9.
Khunamornpong S, Suprasert P, Pojchamarnwiputh S, Na Chiangmai W, Settakorn J, Siriaunkgul S. Primary and metastatic mucinous adenocarcinomas of the ovary: Evaluation of the diagnostic approach using tumour size and laterality. Gynecol Oncol 2006;101(1):152–7.
Jung ES, Bae JH, Lee A, Choi YJ, Park JS, Lee KY. Mucinous Adenocarcinoma Involving the Ovary: Comparative Evaluation of the Classification Algorithms using Tumour Size and Laterality. J Korean Med Sci 2010;25(2):220–5.
Vang R, Gown AM, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, et al. Cytokeratins 7 and 20 in Primary and Secondary Mucinous Tumours of the Ovary: Analysis of Coordinate Immunohistochemical Expression Profiles and Staining Distribution in 179 Cases. Am J Surg Pathol 2006;30(9):1130–9.
Ji H, Isacson C, Seidman JD, Kurman RJ, Ronnett BM. Cytokeratin 7 and 20, Dpc4, and MUC5AC in the Distinction of Metastatic Mucinous Carcinomas in the Ovary From Primary Ovarian Mucinous Tumours: Dpc4 Assists in Identifying Metastatic Pancreatic Carcinomas. Int J Gynecol Pathol 2002;21(4):391–400.
Park SY, Kim HS, Hong EK, Kim WH. Expression of cytokeratin 7 and 20 in primary carcinomas of the stomach and colorectal and their value in the differential diagnosis of metastatic carcinomas to the ovary. Hum Pathol 2002;33(11):1078–85